Mycophenolate sodium (360mg) & MYCOPLASM S 360: Order Sterispharma Pharmaceuticals: Easy and Convenient

MYCOPLASM S 360

Mycophenolate sodium (360mg)

MYCOPLASM S 360, containing Mycophenolate Sodium  360mg strength, is a medication with significant therapeutic applications in immunosuppression. This article aims to provide a comprehensive guide to MYCOPLASM S 360, covering its uses, potential side effects, recommended dosage, and pricing details, offering valuable insights for individuals and healthcare providers.

Understanding MYCOPLASM S 360

MYCOPLASM S 360 leverages the immunosuppressive properties of Mycophenolate Sodium, a medication that plays a vital role in preventing organ rejection in transplant recipients. By inhibiting certain enzymes involved in immune response, Mycophenolate Sodium helps suppress the body's immune system, reducing the risk of rejection and promoting transplant success.

Key Uses of MYCOPLASM S 360

1. Organ Transplant Immunosuppression:
   • MYCOPLASM S 360 is primarily used to prevent organ rejection in kidney, liver, and heart transplant recipients.
2. Autoimmune Diseases:
   • It may be prescribed off-label for certain autoimmune conditions such as lupus nephritis or rheumatoid arthritis in combination with other medications.
3. Dermatological Disorders:
   • In some cases, MYCOPLASM S 360 may be used to manage dermatological conditions with an autoimmune component.

Mechanism of Action

Mycophenolate Sodium, the active component of MYCOPLASM S 360, works by inhibiting inosine monophosphate dehydrogenase (IMPDH) enzymes crucial for the synthesis of guanosine nucleotides in immune cells. This inhibition selectively targets rapidly dividing cells, including activated T and B lymphocytes, leading to immunosuppression.

Recommended Dosage

Dosage recommendations for MYCOPLASM S 360 are typically tailored to individual patient factors and the specific transplant type:

• Kidney Transplant:
  • The initial dosage may range from 720-1440mg daily, divided into two doses.
• Liver Transplant:
  • Dosage adjustments are based on liver function and patient response, with initial doses usually starting at 1440mg daily.
• Heart Transplant:
  • Dosage and titration protocols are determined by healthcare providers based on transplant center guidelines.

Dosage adjustments may be necessary based on kidney function, concurrent medications, and tolerability.

Potential Side Effects of MYCOPLASM S 360

While MYCOPLASM S 360 is generally well-tolerated, some individuals may experience certain side effects, including:

• Infections due to immunosuppression
• Blood disorders like leukopenia or anemia
• Liver function abnormalities
• Skin reactions
• Increased risk of malignancies, particularly skin cancers

Regular monitoring and reporting of any unusual symptoms to healthcare providers are important during Mycophenolate Sodium treatment.

Precautions and Warnings

• Pregnancy and Breastfeeding: MYCOPLASM S 360 is contraindicated during pregnancy due to potential fetal harm. It should not be used during breastfeeding unless deemed necessary and under close medical supervision.
• Infections: Patients taking MYCOPLASM S 360 are at an increased risk of infections. Precautions to prevent infections and regular monitoring are advised.
• Medication Interactions: Inform healthcare providers about all medications, supplements, or herbal products being taken, as interactions with Mycophenolate Sodium may occur.

Price and Availability

MYCOPLASM S 360 is available in pharmacies and typically requires a prescription. Prices can vary based on brand, quantity, and location. It is advisable to check with local pharmacies or online platforms for pricing and availability information.

Conclusion

MYCOPLASM S 360, containing Mycophenolate Sodium 360mg, is a vital medication in transplant immunosuppression and management of certain autoimmune conditions. Understanding its uses, potential side effects, recommended dosage, and pricing details empowers individuals and healthcare providers to make informed decisions.  Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW